InvestorsKeyhole Morning News Leader

Eli Lilly gets FDA approval for new migraine drug

Eli Lilly and Company (LLY) is up 0.1% Friday morning. The company announced the U.S. Food and Drug Administration approved its new migraine drug Emgality. The drug is expected to sell for $575 a month, in-line with two other new drugs that are on the market.

Eli Lilly and Company (LLY) is a drug manufacturer.

Lowe’s Companies, Inc. (LOW) and The Boeing Company (BA) top the list of other companies with positive news today, while Tesla, Inc. (TSLA) and Applied Optoelectronics, Inc. (AAOI) top the list of companies with negative news.

Already a member?

Login to see your Morning News Leader Trade Idea.

Not yet a member?

You can receive four timely bull-put credit spreads each market day by joining our InvestorsKeyhole Daily Trade Alerts Service. Our analysts scour the news looking for unusual options activity, how insiders are trading, and breaking news, and publish trades accordingly.

Become A Member

About Eli Lilly and Company

Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.

  • Last Price:
  • Previous Close:
  • Change:
    $0.29 (0.26%)
  • Open:
  • Volume:
  • Average Volume (100 Day):
  • Market Capitalization:
    $106.7 B
  • Day's Range:
    $109.29 - $111.33
  • Dividend Yield:
  • 52-week Range:
    $132 - $103.25
  • P-E:
  • EPS:
  • Earnings Date:
  • Ex Dividend Date:
  • Sector:
  • Industry:
    Drug Manufacturers - Major
  • Analyst Average Recommendation:
    Moderate Buy

Download this step-by-step guide on placing InvestorsKeyhole Daily Trade Alerts.

How to place a credit spread

How to place a vertical debit spread


You May Also Like